
Sign up to save your podcasts
Or
Dr Surbhi Sidana from Stanford University in California discusses recent updates on chimeric antigen receptor T-cell therapy for the treatment of multiple myeloma.
CME information and select publications here.
4.4
6969 ratings
Dr Surbhi Sidana from Stanford University in California discusses recent updates on chimeric antigen receptor T-cell therapy for the treatment of multiple myeloma.
CME information and select publications here.
127 Listeners
17 Listeners
32 Listeners
15 Listeners
62 Listeners
12 Listeners
0 Listeners
314 Listeners
110 Listeners
26 Listeners
478 Listeners
174 Listeners
48 Listeners
55 Listeners
28 Listeners
165 Listeners
49 Listeners